Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit
Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit
Introduction
A South Carolina jury failed to arrive at a unanimous decision whether Johnson & Johnson was responsible for the death of the 30-year old attorney, whose family claimed she suffered from mesothelioma due to the exposure to J&J's talcum powder containing asbestos traces.
A lawyer for the family insists that the daily use of baby powder led to the death and stated they will retry the case soon. The other defendants, in this case, were the U.S. unit of talc supplier Imerys SA, and a local unit of drugstore chain Rite Aid.
J&J is facing around 9,000 cases over claims that its talcum use led to the diagnosis of ovarian cancer in women due to traces of asbestos present as an ingredient in the baby powder when used for feminine hygiene purposes.
Similar allegations are filed against J&J in state courts in California, New Jersey, and Delaware and consolidated for pre-trial proceedings in the U.S. District Court for the District of New Jersey MDL No. 2738 (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…